The inhibition of FTO reduces GPX4 expression and sensitizes tumor cells to ferroptosis, providing a novel epitranscriptomic mechanism for targeting GPX4 in HNSCC [61]. The gene discussed is FTO; the disease is head and neck squamous cell carcinoma.